PacBio (NASDAQ: PACB) has been selected as a technology partner by the Davos Alzheimer's Collaborative (DAC) for the North African Dementia Registry (NADR) project. The initiative brings together The American University in Cairo and UCL Queen Square Institute of Neurology to create a comprehensive multi-omics dataset focused on Alzheimer's disease and dementia research in North African populations.
The NADR, the first dementia-focused registry of its kind in North Africa, will utilize PacBio's long-read sequencing technology to collect biosamples, conduct cognitive assessments, and perform digital phenotyping. The project aims to address the underrepresentation of North African populations in dementia research, with a particular focus on Egypt's population of over 110 million.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.